Reckitt Benckiser closer to acquiring Adams
This article was originally published in The Tan Sheet
Reckitt Benckiser cleared another hurdle in its quest to purchase U.S.-based Adams Respiratory Therapeutics, completing its previously announced cash tender offer for all outstanding Adams' shares, UK-based firm reports. Reckitt received 95.9% of outstanding Adams' shares by the close of business Jan. 23. The firm plans to finalize the merger Jan. 29 and will pay $60 per share to remaining Adams' stockholders, the same price paid in the tender offer. The merger will expand the U.S. OTC presence of Reckitt, which also owns Boots Healthcare but is primarily a household cleaning business (1"The Tan Sheet" Dec. 17, 2007, p. 5)...
You may also be interested in...
Reckitt-Benckiser's revenues soared 13 percent in fiscal 2008 as health care and personal product sales grew more than twice as fast as its other segments - a trend the firm expects to continue despite private label competition and the global economic slump
Adams Respiratory Therapeutics' products have buoyed Reckitt Benckiser's revenues despite slumping economic conditions and are central to the firm's global growth strategies, executives say
An expanding consumer health and personal care business helped Reckitt Benckiser grow "well above industry average," CEO Bart Becht said during an earnings conference call Feb. 13